PFM Health Sciences’s Liberty Global Class C LBTYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-784,471
Closed -$27.9M 76
2015
Q3
$27.9M Sell
784,471
-1,830,857
-70% -$74M 0.79% 43
2015
Q2
$107M Buy
2,615,328
+1,321,699
+102% +$54.8M 2.71% 8
2015
Q1
$52.1M Buy
1,293,629
+598,159
+86% +$23.7M 1.44% 29
2014
Q4
$27.2M Buy
+695,470
New +$25.4M 0.63% 49
2014
Q2
Sell
-2,162,273
Closed -$71.2M 71
2014
Q1
$71.2M Buy
+2,162,273
New +$72.3M 1.29% 29

Other funds holding LBTYK

PFM Health Sciences's LBTYK Position: Q4 2015 in Review

PFM Health Sciences sold out of Liberty Global Class C (LBTYK) in Q4 2015, closing a stake of 784,471 shares — an estimated $27.9M sold.

PFM Health Sciences first reported a position in LBTYK in Q1 2014 and held it in 5 quarters. The position peaked at $107M in Q2 2015. 404 funds tracked by Wall St. Rank hold LBTYK as of Q4 2015.

  • PFM Health Sciences reported no remaining Liberty Global Class C position as of Q4 2015 after selling out during the quarter.
  • PFM Health Sciences sold 784,471 Liberty Global Class C shares in Q4 2015, an estimated $27.9M.
  • PFM Health Sciences first reported a position in Liberty Global Class C in Q1 2014 and held it in 5 quarters.
  • PFM Health Sciences's Liberty Global Class C position peaked at $107M in Q2 2015.
  • 404 funds tracked by Wall St. Rank held Liberty Global Class C as of Q4 2015.

Based on PFM Health Sciences's 13F filing for Q4 2015, filed 16 Feb 2016.